Search alternatives:
"program implement" » "program improvements" (Expand Search)
"program implementingeding" » "program improvementsingeding" (Expand Search)
"program improvementsingeders" » "program improvementhigher" (Expand Search), "program improvementsmothers" (Expand Search), "program improvementshedges" (Expand Search)
Showing 161 - 180 results of 442 for search '(((("program improvementsingeders") OR ("program implement"))) OR ("program implementingeding"))', query time: 0.24s Refine Results
  1. 161
    Serotype distribution of invasive pneumococcal disease cases<sup>a</sup>, by associated vaccine type, in Ontario, Canada, 2007–2017.

    Serotype distribution of invasive pneumococcal disease cases<sup>a</sup>, by associated vaccine type, in Ontario, Canada, 2007–2017. by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  2. 162
    Number of confirmed invasive pneumococcal disease cases, by associated vaccine type<sup>a</sup> and year, in Ontario, Canada, 2007–2017 (N = 12,377).

    Number of confirmed invasive pneumococcal disease cases, by associated vaccine type<sup>a</sup> and year, in Ontario, Canada, 2007–2017 (N = 12,377). by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  3. 163
    Incidence rates (per 100,000 population) of commonly<sup>a</sup> reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017.

    Incidence rates (per 100,000 population) of commonly<sup>a</sup> reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017. by Shinthuja Wijayasri (8124539)

    Published 2019
    Subjects:
    Save to List
    Saved in:
  4. 164
    VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020).

    VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). by Abigail K. Korn (12096012)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 165
    Same day cryotherapy/thermocoagulation performed by HIV status in Namibia (October 2018 –March 2020).

    Same day cryotherapy/thermocoagulation performed by HIV status in Namibia (October 2018 –March 2020). by Abigail K. Korn (12096012)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 166
    Treatment for cervical pre-cancer lesions and post-treatment complications by age, lesion severity, and HIV status in Namibia (October 2018–March 2020).

    Treatment for cervical pre-cancer lesions and post-treatment complications by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). by Abigail K. Korn (12096012)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 167
    Participant demographics.

    Participant demographics. by Nickolas D. Zaller (8727462)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  8. 168
    Characteristics of participants at baseline of community ART group.

    Characteristics of participants at baseline of community ART group. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 169
    Summary of council demographics and geography.

    Summary of council demographics and geography. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 170
    Total cost of referrals completed for FY2020/21.

    Total cost of referrals completed for FY2020/21. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 171
    The decision tree comparing the cost and effectiveness of the standard referral system and the emergency transport system.

    The decision tree comparing the cost and effectiveness of the standard referral system and the emergency transport system. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 172
    Differences in the participants’ bodyweight, immunologic and virologic status after a year follow-up.

    Differences in the participants’ bodyweight, immunologic and virologic status after a year follow-up. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 173
    Summary of test results after one year of follow-up.

    Summary of test results after one year of follow-up. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 174
    Mean of completed referrals for FY 2020/2021.

    Mean of completed referrals for FY 2020/2021. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 175
    Summary of undiscounted cost and effectiveness for Shinyanga region.

    Summary of undiscounted cost and effectiveness for Shinyanga region. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 176
    Summary of test uptake against results after one year of follow-up.

    Summary of test uptake against results after one year of follow-up. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 177
    Total number of referrals completed.

    Total number of referrals completed. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 178
    Ambulance and drivers distribution.

    Ambulance and drivers distribution. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 179
    Pictograph of community antiretroviral group selection outcomes.

    Pictograph of community antiretroviral group selection outcomes. by Patrick Dakum (364901)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 180
    Cost–effectiveness ranking.

    Cost–effectiveness ranking. by Castory Munishi (9308105)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: